Budget impact assessment of Aprokam® compared with unlicensed cefuroxime for prophylaxis of post-cataract surgery endophthalmitis

BACKGROUND: Intracameral cefuroxime is recommended as prophylaxis against postoperative endophthalmitis (POE) following cataract surgery. Aprokam is the only licensed product for prophylaxis of POE, although unlicensed intracameral cefuroxime may be administered using pre-filled syringes (PFS), eith...

Descripción completa

Detalles Bibliográficos
Autores principales: Purslow, Christine, Davey, Keith, Johnson, Mildred, Pietri, Guilhem, Suri, Gaurav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495806/
https://www.ncbi.nlm.nih.gov/pubmed/26152124
http://dx.doi.org/10.1186/s12886-015-0056-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495806/
https://www.ncbi.nlm.nih.gov/pubmed/26152124
http://dx.doi.org/10.1186/s12886-015-0056-5

Ejemplares similares